𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

✍ Scribed by Emmanouilides, Christos; Witzig, Thomas E.; Gordon, Leo I.; Vo, Katie; Wiseman, Gregory A.; Flinn, Ian W.; Darif, Mohamed; Schilder, Russell J.; Molina, Arturo


Book ID
126614116
Publisher
Informa plc
Year
2006
Tongue
English
Weight
352 KB
Volume
47
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term responses in patients with rec
✍ Thomas E. Witzig; Arturo Molina; Leo I. Gordon; Christos Emmanouilides; Russell πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 205 KB

## Abstract ## BACKGROUND. Radioimmunotherapy with radiolabeled monoclonal antibodies to CD20 produces a high response rate in patients with recurring non‐Hodgkin lymphoma (NHL), but the durability of those remissions is not well defined. ## METHODS. Data on patients with recurring NHL treated w